Effect of omega-3 supplementation on myelination, inflammation, and chronic fatigue in patients with multiple sclerosis
Not Applicable
- Conditions
- Multiple Sclerosis.Multiple sclerosis (of):NOS brain stem cord disseminated generalized
- Registration Number
- IRCT20240604062003N1
- Lead Sponsor
- Abadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age 18-85 years
MS diagnosis by a neurologist based on McDonald's criteria (98)
Under treatment with MS-modifying drugs with a fixed dose from 6 months before enrolling in the study
Exclusion Criteria
Participants in other trials except for the current clinical trial
Recurrence or treatment with corticosteroids in the last month-
Simultaneous treatment with antibiotics and antihypertensive drugs
Other acute or severe diseases except for MS
Pregnancy
Current or past history of ventricular arrhythmia
General health condition that interferes with participation in the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method